Stock Events

Stock Events

Mineralys Therapeutics (MLYS) Q3 2024 Earnings

13AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.83

-0.55

-0.28

0

Details

Expected EPS

-0.7

Actual EPS

-0.83

Surprise EPS

-0.13

Surprise Percent

+18.57%

Description

Mineralys Therapeutics (MLYS) has reported earnings of -0.83 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.